{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:40:03Z","timestamp":1790361603373,"version":"4.1.0"},"reference-count":24,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biomed Mater Res"],"published-print":{"date-parts":[[2006,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sensitivity to implant materials is an unpredictable event, which may contribute to the process leading to the failure of the total hip replacement (THR). The aim of the current study was to investigate the informative power of skin testing in detecting the sensitization to the implant components in patients undergoing THR. A consecutive series of 223 patients was enrolled in the study, including 66 candidates to THR, 53 with stable implant, and 104 with THR loosening. The patch testing was performed by using the most relevant components of cobalt\u2010based alloys (CoCrMo), Ti\u2010based alloys (TiAlV), and bone cements. The frequency of positive patch testing in preimplant patients did not differ from that observed after THR. Patients with CoCrMo\u2010failed implant showed a significant low frequency of nickel\u2010positive skin reaction, while patients with TiAlV\u2010THR had a high incidence of vanadium\u2010positive patch testing. The panel of haptens showed a good performance in the identification of patients known to have a contact dermatitis. With regard to the THR outcome, patch testing was not able to discriminate between stable and failed implant. Sensitivity to at least one hapten, namely bone cement, as well as the positive medical history of hypersensitivity, influenced negatively the THR survival. Our results show the reliability of patch testing for investigating the sensitivity to implant components. The cause\u2013effect relationship between sensitization and negative outcome cannot be established, but the shorter lifespan of THR in patients who have a positive patch testing supports the significant role of this event in contributing to the implant failure. \u00a9 2005 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2006<\/jats:p>","DOI":"10.1002\/jbm.b.30445","type":"journal-article","created":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T19:18:02Z","timestamp":1130872682000},"page":"257-264","source":"Crossref","is-referenced-by-count":105,"title":["Sensitivity to implant materials in patients undergoing total hip replacement"],"prefix":"10.1002","volume":"77B","author":[{"given":"Donatella","family":"Granchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Cenni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Trisolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Giunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,11]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/0-306-47583-9_26"},{"key":"e_1_2_6_3_2","first-page":"1","volume-title":"Guidance for Industry and FDA Reviewers. Immunotoxicity Testing Guidance","author":"Food and Drug Administration (FDA)","year":"1999"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2003.12.024"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1302\/0301-620X.85B5.13729","article-title":"Immunological changes in patients with primary osteoarthritis of the hip after total joint replacement","volume":"85","author":"Granchi D","year":"2003","journal-title":"J Bone Joint Surg Br"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.2106\/00004623-200103000-00017"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.73B1.1991768"},{"key":"e_1_2_6_8_2","first-page":"407","article-title":"Allergy to components of total hip arthroplasty before and after surgery","volume":"18","author":"Cancilleri F","year":"1992","journal-title":"Ital J Orthop Traumatol"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1302\/0301-620X.74B6.1447242","article-title":"Lymphocyte response to polymethylmethacrylate in loose total hip prostheses","volume":"74","author":"Gil\u2010Albarova J","year":"1992","journal-title":"J Bone Joint Surg Br"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.78B4.0780546"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4636(200009)53:5<480::AID-JBM6>3.0.CO;2-B"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0142-9612(00)00099-5"},{"key":"e_1_2_6_13_2","first-page":"57","article-title":"Validity of MELISA for metal sensitivity testing","volume":"24","author":"Valentine\u2010Thon E","year":"2003","journal-title":"Neuro Endocrinol Lett"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4636(199606)31:2<183::AID-JBM4>3.0.CO;2-J"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.orthres.2004.09.001"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s003300050971"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)90194-9"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7379.41"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.2106\/00004623-200403000-00024"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2003.00072.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1993.tb03318.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.107235"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.5.4.430-437.1998"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0142-9612(97)00148-8"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4636(19991215)47:4<543::AID-JBM11>3.0.CO;2-G"}],"container-title":["Journal of Biomedical Materials Research Part B: Applied Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbm.b.30445","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbm.b.30445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T16:47:35Z","timestamp":1697474855000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jbm.b.30445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["10.1002\/jbm.b.30445"],"URL":"https:\/\/doi.org\/10.1002\/jbm.b.30445","archive":["Portico"],"relation":{},"ISSN":["1552-4973","1552-4981"],"issn-type":[{"value":"1552-4973","type":"print"},{"value":"1552-4981","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}